SCHEMBL6083436

SCHEMBL6083436

COc1ccc(-c2nc(N)nc(N)c2N)c(C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NNMT P40261 1/20 0.41
PIK3CA P42336 2/20 0.38
ALDH1A1 P00352 2/20 0.36
DCPS Q96C86 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 1/20 0.35
BRD9 Q9H8M2 1/20 0.35
BRD7 Q9NPI1 1/20 0.35
DHFR P00374 1/20 0.35
PDE10A Q9Y233 3/20 0.35
PDE2A O00408 2/20 0.35
PDE5A O76074 1/20 0.35
PDE7A Q13946 1/20 0.35
PDE11A Q9HCR9 1/20 0.35
PLAU P00749 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6082359 0.80 NNMT (0.40) NNMTPIK3CABRD9BRD7PLAU
SCHEMBL21116462 0.72 ALDH1A1 (0.45) NNMTPIK3CAALDH1A1PIK3CDPIK3CB
SCHEMBL27952809 0.69 MTOR (0.48) PIK3CANPC1RAB9AADORA2AADORA1
SCHEMBL357334 0.68 NNMT (0.53) NNMTPIK3CAALDH1A1NPC1RAB9A
SCHEMBL29743795 0.68 NNMT (0.53) NNMTPIK3CAALDH1A1NPC1RAB9A
SCHEMBL172558 0.67 NNMT (0.52) NNMTALDH1A1BRD9BRD7PDE10A
Hydrochloric Acid SCHEMBL30294545 0.66 NNMT (0.52) NNMTPIK3CAALDH1A1NPC1RAB9A
SCHEMBL16793139 0.66 DPP4 (0.42) NNMTBRD9BRD7PDE10APDE2A
SCHEMBL3179740 0.66 PDE2A (0.44) NNMTBRD9BRD7PDE10APDE2A
SCHEMBL27235504 0.66 NNMT (0.46) NNMTPIK3CAALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067658-B2 Pyridino and pyrimidino pyrazinones BRISTOL-MYERS SQUIBB COMPANY (US) 2006-06-27 US disclosed
US-20040082784-A1 Pyridino and pyrimidino pyrazinones BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-04-29 US disclosed
WO-2004031189-A1 PYRIDINO AND PYRIMIDINO PYRAZINONES FOR TREATMENT OF ANXIETY AND DEPRESSION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2004-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082784-A1 Pyridino and pyrimidino pyrazinones CRHR1, CRHR2, CRH NNMT 3833/4885PIK3CA 2342/4885ALDH1A1 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.